Target 3.A: Implement the WHO framework convention on tobacco control
UN definition: "Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate."
Prevalence of tobacco use - SDG Indicator 3.A.1
Definition: Indicator 3.A.1 is the "age-standardized prevalence of current tobacco use among persons aged 15 years and older".
This measures the share of adults (aged 15+) who smoke tobacco daily.
Goal: By 2030 "Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries". There is no specified target level of tobacco use for this indicator.
Target 3.B: Support research, development and universal access to affordable vaccines and medicines
UN definition: "Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all."
Vaccine coverage - SDG Indicator 3.B.1
Definition: Indicator 3.B.1 is the "proportion of the target population covered by all vaccines included in their national program".
The UN does not currently define which vaccinations are measured by this indicator. The Institute of Health Metrics and Evaluation (IHME) defines this indicator based on the mean coverage of the following eight vaccines:
"three-dose diphtheria, pertussis, and tetanus (DPT3); three-dose polio; first-dose measles vaccine; and for countries where the vaccine(s) are included in the national schedule: BCG vaccine, three-dose pneumococcal conjugate vaccine (PCV3), three-dose Haemophilus influenzae type b vaccine (Hib3), three-dose hepatitis B vaccine (delivered as part of pentavalent vaccines), and two-dose or three-dose rotavirus vaccine"
Goal: By 2030 "provide access to affordable essential medicines and vaccines for all".
For this indicator, means universal coverage of the vaccines noted above (if included in national vaccination programs) must be achieved by 2030.
Development assistance to medical research & basic healthcare - SDG Indicator 3.B.2
Definition: Indicator 3.B.2 is the "total net official development assistance (ODA) to medical research and basic health sectors".
Goal: By 2030 "Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, providing access to affordable essential medicines and vaccines for all".
Availability of essential medicines - SDG Indicator 3.B.3
Definition: Indicator 3.B.3 is the "proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis".
The WHO Taskforce on Innovative International Financing for Health Systems provides a list of medicines considered essential in its Working Group Report.
Goal: By 2030 "provide affordable access to essential medicines for all".
